论文部分内容阅读
近年来已有许多文献报道进口素素治疗晚期复发性卵巢癌，且疗效肯定。但由于价格昂贵，在临床应用中受到很大限制。我院自1996年三月尝试用中国医学科学院药物研究所药厂生产的紫杉醇（商品名紫素）治疗晚期复发性卵巢癌。现将全组9例的临床疗效总结如下。方法9例患者年龄43岁
In recent years, many articles have reported the import of hormone treatment of advanced recurrent ovarian cancer, and the effect is positive. However, due to its high price, it has been greatly restricted in clinical application. Our hospital since March 1996 attempt to use the Chinese Academy of Medical Sciences Institute of Pharmaceutical production of paclitaxel (trade name purple pigment) for the treatment of advanced recurrent ovarian cancer. Now the clinical efficacy of the whole group of 9 cases are summarized as follows. Methods Nine patients were 43 years old